Skip to main content
. 2024 Jul 30;14:17515. doi: 10.1038/s41598-024-67371-5

Figure 6.

Figure 6

Pharmacokinetics and pharmacodynamics of orally administered JNJ-77242113 in a first-in-human study of healthy participants. (A) Mean plasma concentrations of JNJ-77242113 in healthy participants from Part 2 (Day 1 in multiple ascending dose cohorts). Error bars denote standard deviation. (B) Mean concentrations of IL-23–induced IFNγ in whole blood from participants after they had received a single oral dose of JNJ-77242113. Error bars denote standard error of the mean. IFN interferon, IL interleukin.